Speakers

-

We're bringing together internationally recognised experts and emerging leaders from across the Asia-Pacific and beyond to share the latest advances in psychedelic science, clinical practice, and policy. Confirmed speakers for CAPS27, all presenting in-person in Melbourne. More speakers will be announced as the program takes shape.

Subscribe to be the first to know as our line-up is confirmed.

Rick Doblin PhD

Multidisciplinary Association for Psychedelic Studies (MAPS)
Boston, USA

Vidita Vaidya PhD

Tata Institute of Fundamental Research (TIFR)
Mumbai, India

Gül Dölen MD, PhD

University of California, Berkeley
San Francisco, USA

Stephen Ross MD

Center for Psychedelic Medicine, New York University (NYU)
New York, USA

Jem Stone

Indigenous Psychedelic-Assisted Therapies (IPAT)
Nimbin, Australia

Tehseen Noorani PhD

Social and Community Health, Waipapa Taumata Rau, The University of Auckland
Auckland, New Zealand

Jennifer Mitchell PhD

University of California, San Francisco (UCSF)
San Francisco, USA

Bill Richards STM, PhD

Independent consultant
Baltimore, USA

Monica Schweickle MClinPsych

The Psychedelic Consultancy and Peridot Clinic
New South Wales, Australia

Max Wolff PhD

Humboldt University Berlin
Berlin, Germany

Hiroyuki Uchida MD, PhD

Keio University School of Medicine
Tokyo, Japan

Manvir Singh PhD

University of California, Davis
San Francisco, USA

Brian Earp PhD

National University of Singapore
Singapore

Claire Foldi PhD

Department of Physiology, Monash University
Melbourne, Australia

Lowan Stewart MD

Axon Clinic
Oslo, Norway

Vince Polito PhD

Macquarie University
Sydney, Australia

Suresh Muthukumaraswamy PhD

The University of Auckland
Auckland, New Zealand

David Erritzoe MD PhD

Imperial College London
London, United Kingdom

Rosalind McAlpine PhD

University College London
London, United Kingdom

Alex Gearin PhD

Medical Ethics and Humanities Unit, The University of Hong Kong
Hong Kong